Besides affecting the tumor cells, themselves, the TRAIL-induced cancer cell secretome has been shown to promote tumor malignancy by inducing the accumulation of tumor-supporting immune cells in the tumor microenvironment. This evidence concerns the gene TNFSF10 and neoplasm.